Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
暂无分享,去创建一个
D. Levy | R. Vasan | W. Kannel | C. O’Donnell | M. Larson | E. Leip | Jane C. Evans | D. Levy | J. Evans
[1] T. Dawber,et al. Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.
[2] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.
[3] D. Cox,et al. Analysis of Survival Data. , 1986 .
[4] D L Sackett,et al. An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.
[5] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[6] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[7] W. Kannel,et al. High-normal blood pressure progression to hypertension in the Framingham Heart Study. , 1991, Hypertension.
[8] J. Neaton,et al. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.
[9] James D. Neaton,et al. Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men , 1992 .
[10] D. Levy,et al. The natural history of borderline isolated systolic hypertension. , 1993, The New England journal of medicine.
[11] A. Zanchetti,et al. Ultrasonographic evaluation of cardiac and vascular changes in young borderline hypertensives. , 1993, Cardiology.
[12] J. Neaton,et al. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. , 1993, Archives of internal medicine.
[13] P Barham,et al. Management of raised blood pressure in New Zealand: a discussion document. , 1993, BMJ.
[14] P Whelton,et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.
[15] L. Kuller,et al. Impact of systolic and diastolic blood pressure on cardiovascular mortality , 1995 .
[16] D. Sackett,et al. The number needed to treat: a clinically useful measure of treatment effect , 1995, BMJ.
[17] S. Graff-Iversen,et al. Left ventricular diastolic function in young men with high normal blood pressure. , 1996, The Canadian journal of cardiology.
[18] W. Kannel. Blood pressure as a cardiovascular risk factor: prevention and treatment. , 1996, JAMA.
[19] B. Psaty,et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.
[20] Jan A Staessen,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.
[21] J. Cutler,et al. Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.
[22] G. Mancia,et al. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Blood pressure.
[23] A. Dyer,et al. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. , 1998, Archives of internal medicine.
[24] Z. Li,et al. Blood pressure, cholesterol, and stroke in eastern Asia , 1998, The Lancet.
[25] N. Doba,et al. Characteristics of cardiovascular morphology and function in the high-normal subset of hypertension defined by JNC-VI recommendations. , 1999, Hypertension research : official journal of the Japanese Society of Hypertension.
[26] A. Dyer,et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. , 1999, JAMA.
[27] Bruce Neal,et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. , 1999, Journal of hypertension.
[28] R. Collins,et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. , 1999, American journal of epidemiology.
[29] D. Levy,et al. Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study. , 1999, Archives of internal medicine.
[30] P. Whelton,et al. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. , 2000, Hypertension.
[31] E. Feskens,et al. The Relation between Blood Pressure and Mortality Due to Coronary Heart Disease among Men in Different Parts of the World , 2000 .